ViE Awards 2016 – Voting is now open!

After weeks of voting and over 1000 nominations collected, we are happy to announce the highly nominated companies in each category as voted by you and your peers for the 9th annual Vaccine Industry Excellence (ViE) Awards in the following categories Best Clinical Trial Site AND Network Best Contract Research Organization Best Contract Manufacturing Organization Best Production/Process Development  Best Academic Research Team …

Over 600 Vaccine executives confirmed!

In terms of the attendees you will meet at the World Vaccine Congress Washington next month, with weeks to go the event is tracking well ahead of this same point last year. In fact we are estimating a growth in numbers by about 25% overall bringing well over 600 leading vaccine executives to the congress. This means by attending you …

World Vaccine Congress 2015: Industry Insights

The World Vaccine Congress  is the  premier event in the vaccine calendar. It is the place where the vaccine industry meets to discuss scientific and commercial issues around vaccine research, development, manufacture and distribution. With only seven weeks to go till the event, we’re getting pretty excited and we hope you are too!  We’ve been in touch with a few of our …

Top 20 influencers in Asia’s vaccines industry

The Asian vaccine market can be split into two big groups. One is where a hub of innovative ideas and vaccine pipelines are waiting to reach the global market (“producers” or “purchasers”). This would include countries like Japan, Australia and Korea. The other is where a large pool of long unmet medical needs against polio, measles and seasonal influenza is …

CFDA approves production of the first Sabin IPV

China Food and Drug Administration (CFDA) has approved the production of the first inactivated poliomyelitis vaccine made from inactivated Sabin strains (Sabin IPV). It was researched and developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences. Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. It is a virus-transmitted disease that …

Korea’s vaccine manufacturers gain additional support

Good news for Korean vaccine manufacturers—the Korean Ministry of Food and Drug Safety (MFDS), formerly known as Korea Food & Drug Administration (KFDA), shared its plans to further support the domestic vaccine developers and boost their global market share. By growing its WHO pre-qualification counseling and consulting arm, local vaccine manufacturers will be aided with higher chances to obtain WHO …

Cancer vaccine trial in Singapore shows promising signs of success

A cancer vaccine suitable for lung, breast, prostate, colon and ovarian cancer has shown promising results in a vaccine trial conducted in Singapore. It was tested for the first time on four patients with Stage 4 cancer and no major side effects have been observed yet. The vaccine trial was launched by the National Cancer Centre of Singapore in September …

Geographical risk of Dengue and clinical studies conducted by Sanofi Pasteur

Making Dengue the Next Vaccine-Preventable Disease

Each year, there are approximately 50 million Dengue infections and an estimated 500,000 individuals are hospitalized with Dengue haemorrhagic fever. There have been attempts to develop a Dengue vaccine since the 1940s, but due to the limited appreciation of its global disease burden and market value, the industry’s interest deteriorated in the 20th century.   In 2013, the WHO ranked …